Shinya Uematsu

Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer

Tsukasa Hasegawa, Noriko Yanagitani, Hirofumi Utsumi et al. · Anticancer Research · 2019 · 39 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors

Takehiro Tozuka, Satoru Kitazono, Hiroaki Sakamoto et al. · BMC Cancer · 2020 · 39 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatment

Takehiro Tozuka, Satoru Kitazono, Hiroaki Sakamoto et al. · Lung Cancer · 2020 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +11

Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer

K. Takahashi, Yosuke Seto, Koutaroh Okada et al. · Thoracic Cancer · 2020 · 36 citations · Full text

Medicine, Oncology, Pharmacology +14

Histologic transformation of epidermal growth factor receptor–mutated lung cancer

Daichi Fujimoto, Hiroaki Akamatsu, Takeshi Morimoto et al. · European Journal of Cancer · 2022 · 28 citations

Medicine, Oncology, Pathology +16